NYSEMKT: EDVAEndovia Health Sciences Inc Stock
$0.14-0.01 (-6.67%)
Updated Oct 13, 2026
EDVA Price
$0.14
Fair Value Price
N/A
Market Cap
$904.17k
52 Week Low
$0.14
52 Week High
$13.40
P/E
-0.01x
P/B
-0.06x
P/S
-5.26x
PEG
N/A
Dividend Yield
N/A
Revenue
-$360.98k
Earnings
-$17.28M
Gross Margin
-44.7%
Operating Margin
4,127.97%
Profit Margin
5,122.3%
Debt to Equity
-1.07
Operating Cash Flow
-$5M
Beta
0.87
Next Earnings
Nov 18, 2026
Ex-Dividend
N/A
Next Dividend
N/A
EDVA Overview
Splash Beverage Group Incorporated sells various non-alcoholic and alcoholic beverages across multiple channels in the U.S. The company has its own vertically integrated B2B and B2C e-commerce distribution platform called Qplash. Its brands include TapouT and Salt Tequila. SBG was founded in 2012 and is headquartered in Fort Lauderdale, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EDVA's potential to beat the market
- EDVA doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Wine
Industry Rating
F
EDVA
RankedUnranked of 7
RankedUnranked of 7
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $90.43 | C | |
| $127.06 | C | |
| $27.29 | C |
Be the first to know about important EDVA news, forecast changes, insider trades & much more!
EDVA News
Overview
Due Diligence Score
–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EDVA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EDVA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EDVA is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
EDVA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more EDVA due diligence checks available for Premium users.
Valuation
EDVA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.01x
Industry
20.49x
Market
47.92x
EDVA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.06x
Industry
3.14x
EDVA's financial health
Profit margin
Revenue
$0.0
Net Income
-$2.1M
Profit Margin
0%
EDVA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
EDVA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.1M
Liabilities
$16.8M
Debt to equity
-1.07
EDVA's short-term liabilities ($16.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EDVA's short-term assets ($900.41k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EDVA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EDVA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.1M
Investing
$0.0
Financing
$1.2M
EDVA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
EDVA vs Wine Stocks
Endovia Health Sciences Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.